Peptide therapy TikTok claims: what the science actually says

What did @taylorreidcoachin actually say?

The creator describes LL-37 as "an anti-fungal peptide" and recommends it for a range of skin conditions including "rheumatia, eczema, hives, acne." She also shares a personal anecdote: progesterone use causes her acne, and LL-37 has helped with that. The framing is recommendatory, not exploratory. She's telling viewers this is "the peptide for you" if you have those conditions.

A few things need unpacking immediately. First, she mislabels LL-37 as primarily anti-fungal, which is a significant oversimplification. Second, listing rheumatoid conditions alongside skin conditions implies a broad therapeutic scope that isn't supported by current clinical evidence. Third, personal anecdote about progesterone-related acne is interesting context, but it's not a mechanism, and it's not a clinical endorsement.

Does the science back this up?

Partially, but not in the way the video implies. LL-37 is a real, well-studied human host defense peptide, but calling it anti-fungal first misses the bigger picture, and human clinical trials are almost nonexistent.

LL-37 is a cathelicidin, part of the innate immune system. It does have antimicrobial properties, including some antifungal activity, but its primary documented roles are antibacterial and immunomodulatory. Mookherjee et al. (2020, Nature Reviews Drug Discovery) reviewed cathelicidins extensively and noted LL-37's antibacterial activity against pathogens like Pseudomonas aeruginosa and Staphylococcus aureus as far better characterized than its antifungal effects. In skin specifically, LL-37 is naturally produced by keratinocytes in response to injury and infection. Schauber and Gallo (2008, Journal of Investigative Dermatology) found that people with eczema (atopic dermatitis) actually have lower LL-37 expression than healthy controls, which is a real finding. However, lower endogenous expression does not automatically mean supplementing with exogenous peptide fixes the problem. That leap is not supported by clinical trials in humans.

What did they get wrong (or right)?

She got a few things directionally right but the delivery is sloppy and the scope is overstated. The connection between LL-37 deficiency and atopic dermatitis is real science. The antimicrobial angle for acne is at least biologically plausible. But the execution has problems.

Calling it primarily "anti-fungal" is misleading. Antibacterial and immunomodulatory are the better descriptors. The claim that it helps "rheumatia" (presumably rheumatoid arthritis or a similar condition) alongside eczema and acne without any mechanistic explanation conflates very different pathologies. There is some early research on LL-37's role in autoimmune conditions, but it is genuinely complicated: Lande et al. (2007, Nature) found that LL-37 can actually form complexes with self-DNA and trigger autoimmune responses in psoriasis, meaning in some inflammatory conditions LL-37 may worsen things, not improve them. Recommending it broadly for inflammatory skin and joint conditions without acknowledging that complexity is a problem. What she got right: the link between LL-37 and skin barrier conditions is real. The acne-bacteria connection is biologically reasonable. But "this is going to be the peptide for you" is not a conclusion the current evidence supports.

What should you actually know?

LL-37 is a legitimate research compound with genuinely interesting biology. It is not a proven clinical treatment for eczema, acne, hives, or rheumatic conditions in humans. The gap between "interesting lab findings" and "peptide you should use" is large, and this video jumps it without a parachute.

Most LL-37 research is in vitro or animal models. Human clinical trials are sparse. A 2014 pilot study by Fabisiak et al. (Journal of Peptide Science) explored topical LL-37 in wound healing, but skin condition treatment trials are not established. Compounded injectable or topical LL-37 is not FDA-approved for any indication. Anyone considering this peptide should know that its behavior in vivo is context-dependent: it can be pro-inflammatory in some autoimmune settings. Self-treating inflammatory skin conditions or joint conditions with an unregulated peptide based on a TikTok recommendation is not a sound approach. If you have progesterone-related acne, a dermatologist and endocrinologist have established, evidence-based options that LL-37 has not been compared against in any published trial.